Public interest in and acceptability of the prospect of risk-stratified screening for breast and prostate cancer

References

• Burton H, Chowdhury S, Dent T, Hall A, Pashayan N, Pharoah P. Public health implications from COGS and potential for risk stratification and screening. Nature Genetics 2013;45:349–51.
   PubMed Web of Science ®Google Scholar
• Chowdhury S, Dent T, Pashayan N, Hall A, Lyratzopoulos G, Hallowell N, et al. Incorporating genomics into breast and prostate cancer screening: Assessing the implications. Genet Med 2013;15:423–32.
   PubMed Web of Science ®Google Scholar
• Pharoah PD, Antoniou AC, Easton DF, Ponder BA. Polygenes, risk prediction, and targeted prevention of breast cancer. New Engl J Med 2008;358:2796–803.
   PubMed Web of Science ®Google Scholar
• Pashayan N, Duffy SW, Chowdhury S, Dent T, Burton H, Neal DE, et al. Polygenic susceptibility to prostate and breast cancer: Implications for personalised screening. Br J Cancer 2011;104:1656–63.
   PubMed Web of Science ®Google Scholar
• Burton H, Sagoo GS, Pharoah P, Zimmern RL. Time to revisit Geoffrey Rose: Strategies for prevention in the genomic era? Ital J Public Health 2012;9.
   Google Scholar
• Pashayan N, Pharoah P. Population-based screening in the era of genomics. Pers Med 2012;9:451–5.
   PubMed Web of Science ®Google Scholar
• Chowdhury S, Dent T, Pashayan N, Hall A, Lyratzopoulos G, Hallowell N, et al. Incorporating genomics into breast and prostate cancer screening: Assessing the implications. Genet Med 2013;15:423–32.
   PubMed Web of Science ®Google Scholar
• Khoury MJ, Janssens AC, Ransohoff DF. How can polygenic inheritance be used in population screening for common diseases? Genet Med 2013;15:437–43.
   PubMed Web of Science ®Google Scholar
• Schuurman AG, van der Kolk DM, Verkerk MA, Birnie E, Ranchor AV, Plantinga M, et al. Maximising the efficiency of clinical screening programmes: Balancing predictive genetic testing with a right not to know. Eur J Human Genet Epub 2015 Jan 7.
   Google Scholar
• Andrykowski MA, Munn RK, Studts JL. Interest in learning of personal genetic risk for cancer: A general population survey. Prev Med 1996;25:527–36.
   PubMed Web of Science ®Google Scholar
• Cherkas LF, Harris JM, Levinson E, Spector TD, Prainsack B. A survey of UK public interest in internet-based personal genome testing. PloS One 2010;5:e13473.
   PubMed Web of Science ®Google Scholar
• Croyle RT, Lerman C. Interest in genetic testing for colon cancer susceptibility: Cognitive and emotional correlates. Prev Med 1993;22:284–92.
   PubMed Web of Science ®Google Scholar
• Sanderson SC, Wardle J, Jarvis MJ, Humphries SE. Public interest in genetic testing for susceptibility to heart disease and cancer: A population-based survey in the UK. Prev Med 2004;39:458–64.
   PubMed Web of Science ®Google Scholar
• Vermeulen E, Henneman L, van El CG, Cornel MC. Public attitudes towards preventive genomics and personal interest in genetic testing to prevent disease: A survey study. Eur J Public Health 2013:ckt143.
   Google Scholar
• Codori AM, Petersen GM, Miglioretti DL, Larkin EK, Bushey MT, Young C, et al. Attitudes toward colon cancer gene testing: Factors predicting test uptake. Cancer Epidemiol Biomark Prevent 1999;8:345–51.
   PubMed Web of Science ®Google Scholar
• Lerman C, Marshall J, Audrain J, Gomez-Caminero A. Genetic testing for colon cancer susceptibility: Anticipated reactions of patients and challenges to providers. Int J Cancer 1996;69:58–61.
   PubMed Web of Science ®Google Scholar
• Sprangers M, Cull A, Bjordal K, Grønvold M, Aaronson NK. The European Organization for Research and Treatment of Cancer approach to quality of life assessment: Guidelines for developing questionnaire modules. Qual Life Res 1993;2:287–95.
   PubMed Web of Science ®Google Scholar
• Grimm P. Social desirability bias. Wiley International Encyclopedia of Marketing: John Wiley & Sons, Ltd; 2010.
   Google Scholar
• Cameron LD, Diefenbach MA. Responses to information about psychosocial consequences of genetic testing for breast cancer susceptibility: Influences of cancer worry and risk perceptions. J Health Psychol 2001;6:47–59.
   PubMed Web of Science ®Google Scholar
• Lerman C, Croyle RT, Tercyak KP, Hamann H. Genetic testing: Psychological aspects and implications. J Consult Clin Psychol 2002;70:784–97.
   PubMed Web of Science ®Google Scholar
• Dent T, Jbilou J, Rafi I, Segnan N, Tornberg S, Chowdhury S, et al. Stratified cancer screening: The practicalities of implementation. Public Health Genomics 2013;16:94–9.
   PubMed Web of Science ®Google Scholar
• Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, et al. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 1998;90:1371–88.
   PubMed Web of Science ®Google Scholar
• Kettis-Lindblad A, Ring L, Viberth E, Hansson MG. Genetic research and donation of tissue samples to biobanks. What do potential sample donors in the Swedish general public think? Eur J Public Health 2006; 16:433–40.
   Google Scholar